Morphosys (MOR) has released an update.
MorphoSys AG has released a notification of major holdings, revealing that Barclays PLC now holds new voting rights of 3.89% and voting rights through instruments at 3.27%, totalling a combined 7.15% of MorphoSys’ shares. The announcement, dated April 4, 2024, indicates a slight shift in Barclays’ holdings, which previously stood at 7.19%. This move by Barclays PLC underscores its strategic investment changes in the German biopharmaceutical company.
For further insights into MOR stock, check out TipRanks’ Stock Analysis page.
